Can Hereditary Elliptocytosis Be Misdiagnosed as HS?
At a Glance
Yes, severe hereditary elliptocytosis (HE) can be misdiagnosed as hereditary spherocytosis (HS) because they share symptoms like anemia and jaundice. Standard tests like the EMA binding test can show overlapping results, making genetic testing the most reliable way to confirm an exact diagnosis.
In this answer
3 sections
Yes, hereditary elliptocytosis (HE) can be misdiagnosed as hereditary spherocytosis (HS) [1][2]. While they are different conditions, both are red blood cell membrane disorders — genetic conditions that affect the structural integrity of red blood cells.
Most people with HE have a mild condition and experience no symptoms [3]. However, those with severe forms can experience anemia, jaundice (yellowing of the skin or eyes), and an enlarged spleen [4]. Because severe HE shares these symptoms with HS, and because certain subtypes of HE cause the red blood cells to look and behave like those in HS, telling them apart can sometimes be a challenge for doctors [5][1].
The confusion most frequently occurs in two specific, relatively rare subtypes of HE: spherocytic hereditary elliptocytosis and hereditary pyropoikilocytosis (HPP), which is a severe form of HE [2][1]. If you or your child were initially told you might have HS before being diagnosed with HE, it is usually because of how standard blood tests and lab results can overlap between these two conditions.
Why the EMA Binding Test Causes Confusion
The eosin-5-maleimide (EMA) binding test is a widely used screening tool for hereditary spherocytosis [6][7]. This test measures how much of a special fluorescent dye sticks to specific structural proteins (often called Band 3) on the surface of your red blood cells. In a person with HS, there is less Band 3 protein, so the test shows “decreased binding” (less fluorescence) [8][9].
The problem is that the EMA binding test is not perfectly exclusive to HS. Patients with severe forms of HE, such as HPP, or variants like spherocytic HE, also lose pieces of their red blood cell membranes [10][11]. As a result, they can also show decreased EMA binding, leading to a “false positive” interpretation as hereditary spherocytosis [2]. If your doctor relied heavily on this test alone, it is easy to arrive at the wrong diagnosis.
The Role of the Peripheral Blood Smear
A peripheral blood smear involves looking at a drop of your blood under a microscope. Normally, this helps doctors distinguish the two conditions based on cell shape:
- Hereditary Spherocytosis: The red blood cells look like perfect spheres (spherocytes) [12][5].
- Hereditary Elliptocytosis: The red blood cells are stretched into oval or rod-like shapes (elliptocytes) [3][4].
However, in spherocytic HE or HPP, the blood smear shows a confusing “mixed picture.” The smear might contain a combination of elliptocytes, spherocytes, and fragmented cells [1][13]. When a pathologist (a doctor who specializes in analyzing lab samples) sees spherocytes on the slide alongside a positive (decreased binding) EMA binding test, they might quickly conclude it is HS, missing the underlying elliptocytosis [2][11].
Getting a Definitive Diagnosis
When screening tests and blood smears are ambiguous, doctors have two advanced ways to find out for sure whether you have HE or HS:
- Osmotic Gradient Ektacytometry: This specialized test measures how well your red blood cells stretch under stress. HS and HE produce distinctly different curves on this test. HE typically shows a characteristic “trapezoidal” curve, which helps distinguish it from HS [14][15].
- Next-Generation Sequencing (NGS): This is a form of genetic testing that looks directly at your DNA to find the exact mutation causing the disorder [16][17]. Generally, HS is caused by defects in the “vertical” proteins that anchor the cell membrane (like ANK1 or SLC4A1), while HE is usually caused by defects in the “horizontal” proteins that give the cell its flexible skeleton (like SPTA1 or EPB41) [5][17]. However, certain genes, particularly the SPTB gene, can cause either condition depending on the specific location and nature of the mutation [5]. Genetic testing acts as the ultimate tie-breaker, providing a precise diagnosis when standard lab results are unclear [18][19].
Knowing your exact diagnosis is important because it can influence how your condition is monitored and whether certain procedures are recommended. While the vast majority of people with HE require no treatment at all, severe cases might prompt discussions about a splenectomy (surgical removal of the spleen). An accurate diagnosis is crucial here: while spleen removal often resolves anemia completely in HS, it may only partially improve symptoms in severe HE or HPP [18][19].
Common questions in this guide
Why is hereditary elliptocytosis sometimes misdiagnosed as hereditary spherocytosis?
What is the difference between HE and HS on a blood smear?
How can doctors definitively tell HE and HS apart?
Does a misdiagnosis between HE and HS affect treatment?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Did my peripheral blood smear show a mix of spherocytes and elliptocytes, or just one type?
- 2.Was my diagnosis based primarily on an EMA binding test, and if so, how confident are we that it isn't a severe form of HE?
- 3.Should we consider genetic testing (NGS) to confirm exactly which red blood cell membrane disorder I have?
- 4.Based on my specific diagnosis and symptoms, what is the expected long-term management plan, and does it involve monitoring my spleen?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (19)
- 1
Red cell ektacytometry in two patients with chronic hemolytic anemia and three new α-spectrin variants.
Vives-Corrons JL, Krishnevskaya E, Hernández-Rodriguez I, et al.
Annals of hematology 2022; (101(3)):549-555 doi:10.1007/s00277-021-04723-5.
PMID: 34845540 - 2
Analysis of Hereditary Elliptocytosis with Decreased Binding of Eosin-5-maleimide to Red Blood Cells.
Suemori S, Wada H, Nakanishi H, et al.
BioMed research international 2015; (2015()):451861 doi:10.1155/2015/451861.
PMID: 26557672 - 3
A novel EPB41 p.Trp704* mutation in a Korean patient with hereditary elliptocytosis: a case report.
Shin S, Hwang KA, Paik K, Park J
Hematology (Amsterdam, Netherlands) 2020; (25(1)):321-326 doi:10.1080/16078454.2020.1807227.
PMID: 32807033 - 4
A novel mutation in SPTA1 identified by whole exome sequencing in a Chinese family for hereditary elliptocytosis presenting with hyperbilirubinemia: A case report.
Xi Y, Wang L, Zhang P, et al.
Medicine 2019; (98(22)):e15800 doi:10.1097/MD.0000000000015800.
PMID: 31145309 - 5
Inherited hemolytic anemia: a possessive beginner's guide.
Mohandas N
Hematology. American Society of Hematology. Education Program 2018; (2018(1)):377-381 doi:10.1182/asheducation-2018.1.377.
PMID: 30504335 - 6
Evaluation of the Eosin-5'-Maleimide Flow Cytometry Test for the Diagnosis of Hereditary Spherocytosis.
Biaggioni PA, López Romero AC
European journal of haematology 2026; (117(2)):459-466 doi:10.1111/ejh.70204.
PMID: 42046260 - 7
Hereditary Spherocytosis - Diagnosis, Surgical Treatment and Outcomes. A Literature Review.
Manciu S, Matei E, Trandafir B
Chirurgia (Bucharest, Romania : 1990) 2017; (112(2)):110-116.
PMID: 28463670 - 8
[Flow cytometric test using eosin-5'-maleimide (EMA) labelling of red blood for diagnosis of hereditary spherocytosis].
Wang J, Zheng B, Zhao Y, et al.
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2015; (36(7)):598-601 doi:10.3760/cma.j.issn.0253-2727.2015.07.015.
PMID: 26304086 - 9
Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
Arora RD, Dass J, Maydeo S, et al.
International journal of laboratory hematology 2018; (40(3)):335-342 doi:10.1111/ijlh.12794.
PMID: 29573337 - 10
Clinical Diagnosis of Red Cell Membrane Disorders: Comparison of Osmotic Gradient Ektacytometry and Eosin Maleimide (EMA) Fluorescence Test for Red Cell Band 3 (AE1, SLC4A1) Content for Clinical Diagnosis.
Zaidi AU, Buck S, Gadgeel M, et al.
Frontiers in physiology 2020; (11()):636 doi:10.3389/fphys.2020.00636.
PMID: 32636758 - 11
[Band 3 deficiency as a cause of hereditary spherocytosis].
Wada H, Suemori S, Nakanishi H, Sugihara T
[Rinsho ketsueki] The Japanese journal of clinical hematology 2015; (56(7)):837-45 doi:10.11406/rinketsu.56.837.
PMID: 26251147 - 12
A large family of hereditary spherocytosis and a rare case of hereditary elliptocytosis with a novel SPTA1 mutation underdiagnosed in Taiwan: A case report and literature review.
Shih YH, Huang YC, Lin CY, et al.
Medicine 2023; (102(4)):e32708 doi:10.1097/MD.0000000000032708.
PMID: 36705355 - 13
Applications of imaging flow cytometry in the diagnostic assessment of red cell membrane disorders.
More TA, Dalal B, Devendra R, et al.
Cytometry. Part B, Clinical cytometry 2020; (98(3)):238-249 doi:10.1002/cyto.b.21857.
PMID: 31750618 - 14
Use of Laser Assisted Optical Rotational Cell Analyzer (LoRRca MaxSis) in the Diagnosis of RBC Membrane Disorders, Enzyme Defects, and Congenital Dyserythropoietic Anemias: A Monocentric Study on 202 Patients.
Zaninoni A, Fermo E, Vercellati C, et al.
Frontiers in physiology 2018; (9()):451 doi:10.3389/fphys.2018.00451.
PMID: 29755372 - 15
Osmotic gradient ektacytometry: A valuable screening test for hereditary spherocytosis and other red blood cell membrane disorders.
Llaudet-Planas E, Vives-Corrons JL, Rizzuto V, et al.
International journal of laboratory hematology 2018; (40(1)):94-102 doi:10.1111/ijlh.12746.
PMID: 29024480 - 16
Hereditary Spherocytosis: Can Next-Generation Sequencing of the Five Most Frequently Affected Genes Replace Time-Consuming Functional Investigations?
Häuser F, Rossmann H, Adenaeuer A, et al.
International journal of molecular sciences 2023; (24(23)) doi:10.3390/ijms242317021.
PMID: 38069343 - 17
Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis.
Niss O, Chonat S, Dagaonkar N, et al.
Blood cells, molecules & diseases 2016; (61()):4-9.
PMID: 27667160 - 18
Novel mutations in patients with hereditary red blood cell membrane disorders using next-generation sequencing.
He Y, Jia S, Dewan RK, Liao N
Gene 2017; (627()):556-562 doi:10.1016/j.gene.2017.07.009.
PMID: 28694211 - 19
Hereditary Spherocytosis: Linking Ion Transport Defects to Osmotic Gradient Ektacytometry Profiles-A Review.
Vives-Corrons JL, Krishnevskaya E
International journal of molecular sciences 2026; (27(2)) doi:10.3390/ijms27020721.
PMID: 41596371
This information about diagnosing red blood cell disorders is for educational purposes only. Always consult a hematologist to interpret your specific blood smear, genetic tests, and lab results.
Get notified when new evidence is published on Hereditary elliptocytosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.